Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial

Ruhnke, Leo and Roellig, Christoph and Herold, Sylvia and Sauer, Tim and Brandts, Christian H. and Steffen, Bjoern and Schaefer-Eckart, Kerstin and Krause, Stefan W. and Haenel, Mathias and Reichle, Albrecht and Scholl, Sebastian and Neubauer, Andreas and Mikesch, Jan-Henrik and Schetelig, Johannes and Stoelzel, Friedrich and Kramer, Michael and Haake, Annett and Frimmel, Julia and Kraemer, Alwin and Schlenk, Richard and Platzbecker, Uwe and Serve, Hubert and Baldus, Claudia D. and Mueller-Tidow, Carsten and Aust, Daniela and Bornhaeuser, Martin and Ehninger, Gerhard and Thiede, Christian (2023) Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial. HAEMATOLOGICA, 108 (9). pp. 2520-2525. ISSN 0390-6078, 1592-8721

Full text not available from this repository. (Request a copy)

Item Type:	Article
Uncontrolled Keywords:	INV(16); CANCER; ADULTS
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User:	Dr. Gernot Deinzer
Date Deposited:	24 Apr 2024 08:35
Last Modified:	24 Apr 2024 08:35
URI:	https://pred.uni-regensburg.de/id/eprint/60787

Actions (login required)

View Item